Ledger.Open graph →
SEC Form D · filed December 5, 2016

Trieza Therapeutics, Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

David Cordo · Cambridge, MAExecLuke Evnin · Cambridge, MADirectorDaniel Hicklin · Cambridge, MAExec · DirectorKyle Sale · Boise, IDDirectorDavid Cordo · Cambridge, MAExecArthur Dzaghgouni · Grand Cayman, Cayman IslandsExec · DirectorMicah Johnson · Boise, IDExecPete Hartigan · San Francisco, CAExec · DirectorDavid R. Mchale · Wilton, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗